{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:23:04Z","timestamp":1783768984439,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jaclp.2025.06.007","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T02:50:00Z","timestamp":1750474200000},"page":"429-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Management of Relapsing Catatonia After Lorazepam Discontinuation: A Systematic Review of Published Case Reports"],"prefix":"10.1016","volume":"66","author":[{"given":"Olivia","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"McLay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Glue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8271-4255","authenticated-orcid":false,"given":"Yoram","family":"Barak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaclp.2025.06.007_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5498\/wjp.v6.i4.391","article-title":"Catatonia: our current understanding of its diagnosis, treatment and pathophysiology","volume":"6","author":"Rasmussen","year":"2016","journal-title":"World J Psychiatry"},{"key":"10.1016\/j.jaclp.2025.06.007_bib2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/neurolint13040057","article-title":"Catatonia: clinical overview of the diagnosis, treatment, and clinical challenges","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol Int"},{"key":"10.1016\/j.jaclp.2025.06.007_bib3","first-page":"357","article-title":"Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam","volume":"51","author":"Rosebush","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaclp.2025.06.007_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/YCT.0b013e3181fe28bd","article-title":"Catatonia in diagnostic and statistical manual of mental disorders","volume":"26","author":"Francis","year":"2010","journal-title":"J ECT"},{"key":"10.1016\/j.jaclp.2025.06.007_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11920-010-0113-y","article-title":"Catatonia: diagnosis, classification, and treatment","volume":"12","author":"Francis","year":"2010","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.jaclp.2025.06.007_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/104012371803000209","article-title":"Catatonia in the medically ill: etiology, diagnosis, and treatment. The academy of consultation-liaison psychiatry evidence-based medicine subcommittee monograph","volume":"30","author":"Denysenko","year":"2018","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.jaclp.2025.06.007_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.schres.2013.04.034","article-title":"Catatonia in DSM-5","volume":"150","author":"Tandon","year":"2013","journal-title":"Schizophrenia Res"},{"key":"10.1016\/j.jaclp.2025.06.007_bib8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.12968\/hosp.1999.60.11.1235","article-title":"Catatonia. 2: diagnosis, management and prognosis","volume":"60","author":"Clark","year":"1999","journal-title":"Hosp Med"},{"key":"10.1016\/j.jaclp.2025.06.007_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0920-9964(99)00189-9","article-title":"Delayed onset of late movement-related cortical potentials and abnormal response to lorazepam in catatonia","volume":"44","author":"Northoff","year":"2000","journal-title":"Schizophrenia Res"},{"key":"10.1016\/j.jaclp.2025.06.007_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/02698811231158232","article-title":"Evidence-based consensus guidelines for the management of catatonia: recommendations from the British Association for Psychopharmacology","volume":"37","author":"Rogers","year":"2023","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jaclp.2025.06.007_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/schbul\/sbp141","article-title":"Catatonia and its treatment","volume":"36","author":"Rosebush","year":"2009","journal-title":"Schizophrenia Bull"},{"key":"10.1016\/j.jaclp.2025.06.007_bib12","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3390\/bs5040576","article-title":"The syndrome of catatonia","volume":"5","author":"Wilcox","year":"2015","journal-title":"Behav Sci (Basel)"},{"key":"10.1016\/j.jaclp.2025.06.007_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00004714-199002000-00024","article-title":"Lorazepam as an adjunct in the treatment of catatonic states: an open clinical trial","volume":"10","author":"Yassa","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jaclp.2025.06.007_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/0253-7176.207338","article-title":"The phenomenology and treatment response in catatonia: a hospital based descriptive study","volume":"39","author":"Swain","year":"2017","journal-title":"Indian J Psychol Med"},{"key":"10.1016\/j.jaclp.2025.06.007_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fpsyt.2014.00181","article-title":"A clinical review of the treatment of catatonia","volume":"5","author":"Sienaert","year":"2014","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jaclp.2025.06.007_bib16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/B978-0-444-64012-3.00025-3","article-title":"The psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystonia","volume":"165","author":"Sienaert","year":"2019","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.jaclp.2025.06.007_bib17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/00048670701400032","article-title":"Idiopathic recurrent catatonia needs maintenance lorazepam: case report and review","volume":"41","author":"Manjunatha","year":"2007","journal-title":"Aust New Zealand J Psychiatry"},{"key":"10.1016\/j.jaclp.2025.06.007_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0447.1996.tb09815.x","article-title":"Catatonia. II. Treatment with lorazepam and electroconvulsive therapy","volume":"93","author":"Bush","year":"1996","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jaclp.2025.06.007_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s13256-021-03000-3","article-title":"Refractory catatonia in old age: a case report","volume":"15","author":"Bean","year":"2021","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jaclp.2025.06.007_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/10401230009147094","article-title":"Catatonia in a psychiatric intensive care facility: incidence and response to benzodiazepines","volume":"12","author":"Lee","year":"2000","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.jaclp.2025.06.007_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/NDT.S147897","article-title":"Systematic review of catatonia treatment","volume":"14","author":"Pelzer","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.jaclp.2025.06.007_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41398-018-0192-9","article-title":"Review of withdrawal catatonia: what does this reveal about clozapine?","volume":"8","author":"Lander","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jaclp.2025.06.007_bib23","first-page":"41","article-title":"The pharmacotherapy of catatonia","volume":"17","author":"Carroll","year":"2010","journal-title":"Prim Psychiatry"},{"key":"10.1016\/j.jaclp.2025.06.007_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.schres.2023.02.015","article-title":"Lorazepam in catatonia\u2013Past, present and future of a clinical success story","volume":"263","author":"Hirjak","year":"2023","journal-title":"Schizophrenia Res"},{"key":"10.1016\/j.jaclp.2025.06.007_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ajp.2017.04.002","article-title":"Resurgence of catatonia following tapering or stoppage of lorazepam - a case series and implications","volume":"28","author":"Ali","year":"2017","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.jaclp.2025.06.007_bib26","series-title":"Annales M\u00e9dico-psychologiques, revue psychiatrique","article-title":"Medical and mental disorder: proposed definition and criteria","year":"2018"},{"key":"10.1016\/j.jaclp.2025.06.007_bib27","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0022-3565(25)22587-3","article-title":"Benzodiazepine receptor occupancy in vivo: correlation with brain concentrations and pharmacodynamic actions","volume":"240","author":"Miller","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaclp.2025.06.007_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1360-0443.2008.02364.x","article-title":"Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis","volume":"104","author":"Parr","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.jaclp.2025.06.007_bib29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(91)90131-E","article-title":"In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non-human primates","volume":"557","author":"Brouillet","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.jaclp.2025.06.007_bib30","first-page":"243","article-title":"Maintenance treatment of catatonia with benzodiazepines: a case series and literature review","volume":"26","author":"Zwiebel","year":"2024","journal-title":"Neuropsychopharmacol Hung"},{"key":"10.1016\/j.jaclp.2025.06.007_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102507","article-title":"Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review","volume":"70","author":"Brandt","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jaclp.2025.06.007_bib32","series-title":"The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs By Mark Horowitz and David Taylor Wiley-Blackwell","first-page":"1","author":"Hodson","year":"2024"}],"container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296025005099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296025005099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T20:00:09Z","timestamp":1759867209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667296025005099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2667296025005099"],"URL":"https:\/\/doi.org\/10.1016\/j.jaclp.2025.06.007","relation":{},"ISSN":["2667-2960"],"issn-type":[{"value":"2667-2960","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Relapsing Catatonia After Lorazepam Discontinuation: A Systematic Review of Published Case Reports","name":"articletitle","label":"Article Title"},{"value":"Journal of the Academy of Consultation-Liaison Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaclp.2025.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}